CN107096062A - A kind of preparation method and application of the dressing for skin containing carragheen/agarose - Google Patents

A kind of preparation method and application of the dressing for skin containing carragheen/agarose Download PDF

Info

Publication number
CN107096062A
CN107096062A CN201710169113.8A CN201710169113A CN107096062A CN 107096062 A CN107096062 A CN 107096062A CN 201710169113 A CN201710169113 A CN 201710169113A CN 107096062 A CN107096062 A CN 107096062A
Authority
CN
China
Prior art keywords
carragheen
agarose
dressing
skin
freeze
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710169113.8A
Other languages
Chinese (zh)
Inventor
毛萱
黄永睿
汤顺清
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jinan University
Original Assignee
Jinan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jinan University filed Critical Jinan University
Priority to CN201710169113.8A priority Critical patent/CN107096062A/en
Publication of CN107096062A publication Critical patent/CN107096062A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/425Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/26Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • A61L2300/232Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/408Virucides, spermicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents

Abstract

The invention discloses a kind of preparation method and application of the dressing for skin containing carragheen/agarose.Described skin wound dressing is using mass ratio as (10 by carragheen and agarose:90)~(50:50) laminated film is obtained by convection drying after being blended, or freeze-drying obtains the compound rest with three-dimensional porous layer structure;Described carragheen is carragheen of the commerical grade carragheen after purification processes.The carragheen method of purification that the present invention is used solves the problem of carragheen differs greatly between commerical grade carragheen purity deficiency, each manufacturer, it is prepared the high biomaterial of stability.Dressing for skin obtained by the present invention can play organization healing and provide certain nutrition; and protect the surface of a wound, resistance virus to prevent the discovery of infection during organization healing; vivo immuning system partial function can be adjusted in the process simultaneously, veritably play the effect for promoting the surface of a wound to recover healing.

Description

A kind of preparation method and application of the dressing for skin containing carragheen/agarose
Technical field
The invention belongs to biomedical materials field, and in particular to a kind of dressing for skin containing carragheen/agarose Preparation method and application.
Background technology
Carragheen (Carrageenan), also known as antler glue, are that one kind is extracted in marine red alga and gone out, with linear The anion polysaccharide that sulphation galactan is polymerized.Since being found from 20th century by scientist, carragheen is widely used It is used in systematism processing, thickener and as gel-forming component among food and medicine industry.By years development, card Glue is drawn already to turn into one of big algin in the world three.According to the difference in its structure, current commercialized carragheen is mainly κ Type, ι types, three kinds of λ types, wherein with the carrageenan sulfated degree of esterification highest of λ types.Early in 1972, U.S.'s food and drug surveilance Management board (Food And Drugs Administration) divides carragheen group in the classification of " Generally Recognized as safe ", meanwhile, Because carragheen the separation of pre- grease-proof and can provide the property of nutrition, FDA also allows it to be applied to the production such as baby's dairy produce Among product.In 2001, FAO (Food and Agriculture Organization of the United Nation) and the additive Committee of Experts of the World Health Organization eliminated and are directed to OK a karaoke club The limitation of glue acceptable daily intake, it is a kind of safe and nontoxic, addition for having no side effect further to confirm carragheen Agent.Part carragheen has excellent gel-forming property, and such as κ carragheens itself have gel characteristic, and have in the solution micro- The K of amount+In the presence of ion, gel strength will be greatly promoted, and be conducive to the application in food service industry.Except this it Outside, its many potential medical value that carragheen is also exhibited, make it also gradually obtain widely should among pharmaceuticals industry With.In gradually in-depth study, carragheen to it is many virus (such as:Herpesviral, inhibition of HIV etc.) there is the inhibitory activity of wide spectrum Effect.Especially λ carragheens can by adsorption process of the blocking virus to host cell so that suppress herpesviral (HSV-1, Infecting HSV-2), its activity is relevant with sulfur content.In addition carragheen is in terms of antitumor, antiviral, reducing blood lipid, anti-agglomeration On have good effect, also have to the regulation of immune system and have certain effect.It can belong to natural many due to carragheen itself The characteristic of sugar, its species is various.Obtained carragheen is extracted in marine red alga not of the same race in nature in composition and sulphur It is different the index such as Esterification, or even also can in the carragheen property that marine red alga of the same race is obtained by distinct methods extraction Difference.Commercially, different company is prepared and the commerical grade carragheen sold component with it is otherwise varied in purity, Carragheen not of the same race may be present in certain single commerical grade carragheen simultaneously.Card is limited in these characteristic parts Glue is drawn to need the application and development of the technical field of biological material of higher stability.
Agarose is a kind of linear polysaccharide for proposing to obtain among tangleweed, and it has hydrophily, electroneutral, chemistry The properties such as stability and abundance, it is with low cost, food service industry has been widely used to since self-discovery.Agarose dissolves in 90 DEG C hot water formation solution, when its aqueous solution drops to 35 DEG C or so, never random coil gradually becomes list to agarose molecules Chain or double-stranded helical coil conformation, helical conformation connect the tridimensional network of formation rule arrangement with flexible chain, finally Make agarose solution gelation.Compared with other gel rubber materials, Ago-Gel has suitable advantage in mechanical performance (such as:Viscoplasticity, compressibility etc.) and have more superior biocompatibility, a degradability.In view of above advantageous property, agarose should Research for field of tissue engineering technology has been carried out the quite a while, and in terms of nerve, cartilage, mucous membrane of mouth, cornea Achieve some gratifying achievements in research.But because special anti-of Ago-Gel is adhered characteristic, it is not used alone, need With other materials it is used in conjunction with that composite is made improving the cell adhesion of obtained material.Current Ago-Gel exists Sufficiently studied and applied in the fields such as cartilage filling renovation material, bone impairment renovation material, injured nerve protection materials.
Skin, is the maximum organ of human body, accounts for 16% or so of normal person's body weight.As the most key between human body and environment Physical barriers, skin undertake this it is many maintain human normals operation important physiological functions.Control section material (water, electrolysis Matter etc.) human body is passed in and out, stops various types of radiation, completely cut off the part that extraneous harmful substance is this variety of important physiological function.Can As the first line of defence of human body, when wound occurs, skin is then to stand in the breach to sustain damage.In view of skin injury is universal Property, the research for the dressing of skin repair is also valued by people.Skin repair is divided into four-stage:1) hemostasis, 2) inflammation Disease, 3) propagation, 4) remodeling.Each stage is directed to, different requirements are also generated in the performance to dressing for skin.It is preferable Dressing for skin should have:1) contribute to blood coagulation, prevent wound Continuous hemorrhage from deteriorating;2) protect the surface of a wound ventilative while not by the external world Harmful substance infects;3) dressing mitigates pain and does not glue wound when using, it is to avoid secondary insult is caused during taking-up;4) it is easy to make With, be not required to frequently replacing.
In existing market in the prior art, existing many casting products:1) collagen/nylon;2) collagen/agar;3) silk egg In vain;4) acellular dermal matrix;5) other natural or artificial synthesized macromolecules etc..These products are to be based on collagen/sulphur mostly The materials such as aching and limp ossein, collagen/nylon, collagen/silicon rubber, existing market occupation rate is low, using less.
In existing skin ultrastructure material, because of carragheen own partial characteristic, seldom make to itself and its derivative For raw material and related component application.But carragheen is nontoxic and with good gelling performance, has partial monopoly to be related to OK a karaoke club Glue is as the gelling agent of the materials such as capsule, jelly, and such as patent CN201510654564.1 is by carrageenan treatment as plant flexible glue Capsule material;κ, ι type carrageenan treatment are used for non-gelatin capsules shell etc. by patent CN03806246.1.
The content of the invention
In order to solve the deficiency and technical problem of existing dressing for skin, and commerical grade carragheen is being asked present on application Topic, primary and foremost purpose of the invention is to provide a kind of dressing for skin containing carragheen/agarose.The dressing can be organization healing Certain nutrition is provided, and protects the surface of a wound, resistance virus to prevent the discovery of infection during organization healing, while in the process Vivo immuning system partial function can be adjusted, veritably plays a part of promoting the surface of a wound to recover healing.
Another object of the present invention is to provide the preparation method of the above-mentioned dressing for skin containing carragheen/agarose.Should The commerical grade carragheen that method effectively solves different company is used to causing property when prepared by biomaterial that difference to be asked Topic, makes obtained timbering material stability be significantly improved.
A further object of this patent is the application for providing the above-mentioned dressing for skin containing carragheen/agarose.
In order to realize foregoing invention, the present invention takes following technical scheme to implement:
A kind of dressing for skin containing carragheen/agarose, described dressing for skin be by carragheen and agarose with (10:90)~(50:50) after mass ratio blending, be cooled into gel has three-dimensional porous layer by what freeze-drying was obtained again The laminated film that convection drying is obtained after the compound support frame material of shape structure, or blending;Described carragheen is commerical grade card Draw carragheen of the glue after purification processes.
The skin extra earning repair materials of the present invention can play organization healing and provide certain nutrition, and in organization healing The period protection surface of a wound, resistance virus prevent the discovery of infection, while can adjust vivo immuning system partial function in the process, inhale Draw neutrophil leucocyte and reach impaired place, accelerating wound healing veritably plays the effect for promoting the surface of a wound to recover healing.
The purification processes step is:Preparation mass fraction is 10% commerical grade carrageenan solutions, is placed in 90 DEG C of water-baths Dissolve by heating, filter while hot;Add same volume 0.8mol/L KCl solution;Stand or centrifuge at room temperature, take precipitation to be placed in Dialysed three days in bag filter, concentrated by rotary evaporation;Stay overnight, be freeze-dried in -20 DEG C of deep colling.
Described carragheen is that commerical grade carragheen passes through purification processes, improves required compositional purity and removes deimpurity card Draw glue.
It is preferred that, the carragheen includes one kind in κ types carragheen, ι types carragheen, λ type carragheens.
It is preferred that, described three-dimensional porous layer structure compound rest thickness is 3~3.5 millimeters.
It is preferred that, described laminated film thickness is 2~2.5 millimeters.
The above-mentioned dressing for skin containing carragheen/agarose is prepared using following steps:
(1) it is 10% commerical grade carrageenan solutions to prepare mass fraction, is placed in 90 DEG C of water-baths and dissolves by heating, while hot mistake Filter;Add same volume 0.8mol/L KCl solution;Stand or centrifuge at room temperature, take precipitation to be placed in bag filter and dialyse three My god, concentrated by rotary evaporation;Stay overnight, be freeze-dried in -20 DEG C of deep colling, it is standby;
(2) with the pure water dissolving agarose for being heated to 75~90 DEG C, be stirred continuously, obtain uniform, mass concentration be 1~ 2% agarose solution;
(3) carragheen for purifying step (1) is added in step (2) in the agarose solution of gained, and temperature is maintained at 75~90 DEG C, during which stir and evenly mix, obtain carragheen/agarose blend solution, the mass ratio of wherein carragheen/agarose is (10:90)~(50:50);
(4) blend solution obtained by step (3) is poured into convection drying in mould, obtains laminated film;Or it is molten mixing Liquid is poured into mould, is placed under -20 DEG C of environment and is freezed freeze-drying after 4~5h, obtains answering with three-dimensional porous layer structure Close timbering material.
Step (1) described carragheen preferably includes one kind among κ types carragheen, ι types carragheen, λ type carragheens.
When the carragheen is commerical grade kappa-carrageenan, specific purification step is as follows:
Preparation mass fraction is 10% commerical grade kappa-carrageenan solution, is placed in 90 DEG C of water-baths and dissolves by heating, filters while hot; Add same volume 0.8mol/L KCl solution;Stand at room temperature, abandoning supernatant is decanted;Insert and dialyse three in bag filter My god, concentrated by rotary evaporation;- 20 DEG C of deep colling are stayed overnight, freeze-drying, standby.
When the carragheen is commerical grade ι-carragheen, specific purification step is as follows:
Preparation mass fraction is 10% ι-carrageenan solutions, is placed in 90 DEG C of water-baths and is heated to being completely dissolved, filters while hot; Add same volume 0.8mol/L KCl solution;High speed centrifugation, abandoning supernatant;Taking precipitate is dialysed three days in bag filter, Concentrated by rotary evaporation;- 20 DEG C of deep colling are stayed overnight, freeze-drying, standby.The ι-carragheen purification step high speed centrifugal condition is 8000rpm, 20min.
When the carragheen is commerical grade lambda-carrageenan, specific purification step is as follows:
Preparation mass fraction is 10% lambda-carrageenan solution, is placed in 90 DEG C of water-baths and is heated to being completely dissolved, filters while hot; Add same volume 0.8mol/L KCl solution;High speed centrifugation, takes supernatant in clean beaker;Add two volumes anhydrous Ethanol, decantation;Take precipitation to be placed in bag filter to dialyse three days, concentrated by rotary evaporation;- 20 DEG C of deep colling are stayed overnight, freeze-drying, standby.Institute Lambda-carrageenan purification step high speed centrifugal condition is stated for 8000rpm, 10min.
It is preferred that, the bag filter molecular cut off used in being dialysed described in step (1) is 3000.
It is preferred that, mixing speed described in step (2) is 600r/min.
It is preferred that, stir to stir untill mixing is completely with 600r/min at 75~90 DEG C described in step (3).
It is preferred that, the convection drying described in step (4) is that mould is placed at 20~35 DEG C to dry 48~72h, gained Dressing for skin containing carragheen/agarose is laminated film.
It is preferred that, the freeze-drying described in step (4) is to be freezed at -20~-30 DEG C after 4~5h, in freeze-drying Machine cold-trap is -30~-60 DEG C, is evacuated in the state of vacuum and dries 36~48h, the skin containing carragheen/agarose of gained Dressing is the compound support frame material with three-dimensional porous layer structure.
The above-mentioned dressing for skin containing carragheen/agarose can be answered in dressing for skin and tissue engineering bracket material field With.
Room temperature of the present invention refers to 0~30 DEG C.
Compared with prior art, the present invention has advantages below and beneficial effect:
(1) dressing for skin provided by the present invention containing carragheen/agarose can provide nutrient energy to wound site, And because of carragheen special property, during use the surface of a wound can be protected not to be infected by the virus, maintain normal healing process.
(2) commerical grade carragheen method of purification provided by the present invention can separate different types of carragheen, needed for making Specific carragheen content be greatly improved so that steady using the dressing for skin of carragheen/agarose obtained by it Qualitative stronger, every property is consistent.
(3) extensively, manufacturing cost is low for the dressing for skin raw material sources provided by the present invention containing carragheen/agarose, And it is strong in improving raw material added value, (carragheen, agarose are all by large-scale for the development of the marine alga plantation industry of promotion surrounding area Extracted in marine alga).
(4) dressing for skin provided by the present invention containing carragheen/agarose is easy to use, and with good moistening Property, adhesion will not be produced to the surface of a wound, the generation of secondary insult when preventing from taking out.
(5) dressing for skin provided by the present invention containing carragheen/agarose has a wide range of application, and can be applied to burn, In the large area skin wound repair such as skin ulcer.And relative to the existing dressing such as agarose/collagen, in stability and intensity Increase, dressing of the invention is in value of the biomedical materials field with more application.
Brief description of the drawings
Fig. 1 is obtained κ types carragheen/agarose compound rest cross section SEM figures made from embodiment 2.
Fig. 2 is ι types carragheen/agarose compound rest cross section SEM figures obtained by embodiment 3.
Embodiment
With reference to embodiment and accompanying drawing, the present invention is described in further detail, but embodiments of the present invention are not limited In this.
Embodiment 1
A kind of dressing for skin laminated film containing λ types carragheen/agarose, be by λ types carragheen and agarose according to 50:The laminated film that 50 mass ratio is constituted.
The preparation method of the above-mentioned dressing for skin laminated film containing λ types carragheen/agarose comprises the following steps:
(1) it is 10% commerical grade lambda-carrageenan solution to prepare mass fraction, is placed in 90 DEG C of water-baths and is heated to being completely dissolved, Filter while hot.Add same volume 0.8mol/L KCl solution.50mL centrifuge tubes high speed centrifugation (8000rpm, 10min) is inserted, Supernatant is taken in clean beaker.Add two volumes absolute ethyl alcohol, decantation.Precipitation is taken to be placed in the dialysis of molecular cut off 3000 Dialysed three days in bag, concentrated by rotary evaporation.It is placed in deep colling in -20 DEG C of refrigerators to stay overnight, is freeze-dried.
(2) agarose is dissolved with 90 DEG C of pure water, obtains the agarose solution that mass fraction is 1%.
(3) the λ type carragheens purified are added in above-mentioned agarose solution, and in 80 DEG C, 600r/min condition Under be stirred continuously make its be well mixed, solution bubble-free obtains carragheen/agarose blend solution.Wherein carragheen and agar The mass ratio of sugar is 50:50.
(4) blend solution obtained by step (3) is poured into mould and cooled down, the height of blend solution in a mold is about 3 millis λ types carragheen/agarose laminated film is made in rice, convection drying 36h under the conditions of mould then is placed in into 20~35 DEG C.
The lambda-carrageenan in step (1) before and after purification is taken to carry out elementary analysis, as a result as shown in table 1, λ-OK a karaoke club after purification Glue content is greatly improved.
The lambda-carrageenan elementary analysis result of table 1
Lambda-carrageenan Sulfur content (%) Sulfate group content (%)
Before purification 7.20 18.00
After purification 9.75 24.38
Obtained λ types carragheen/agarose laminated film thickness is about 2~2.5 millimeters, Co 60 illumination-based disinfection standby With.
Embodiment 2
A kind of dressing for skin compound rest containing κ types carragheen/agarose, be by κ types carragheen and agarose according to 40:The compound support frame material that 60 mass ratio is constituted, stretch modulus 0.292MPa.
The preparation method of the above-mentioned dressing for skin compound rest containing κ types carragheen/agarose, comprises the following steps:
(1) it is 10% commerical grade kappa-carrageenan solution to prepare mass fraction, is placed in 90 DEG C of water-baths and dissolves by heating, while hot mistake Filter.Add same volume 0.8mol/L KCl solution.Stand at room temperature, abandoning supernatant is decanted.Inserting molecular cut off is Dialysed three days in 3000 bag filter, concentrated by rotary evaporation.Insert deep colling in -20 DEG C of refrigerators to stay overnight, be freeze-dried.
(2) agarose is dissolved with 90 DEG C of pure water, obtains the agarose solution that mass fraction is 1%.
(3) the κ type carragheens purified are added in above-mentioned agarose solution, and in 80 DEG C, 600r/min condition Under be stirred continuously make its be well mixed, solution bubble-free obtains carragheen/agarose blend solution.Wherein carragheen and agar The mass ratio of sugar is 40:60.
(4) blend solution obtained by step (3) is poured into mould and cooled down, the height of blend solution in a mold is about 4 millis Rice, is then placed in 4~5h of freezing at -20 DEG C by mould.The mould of deep colling is put into freeze drier, condenser temperature for- 30~-60 DEG C, pumping freeze-drying 36h under conditions of vacuum, are made κ types carragheen/agarose compound rest.
Obtained κ types carragheen/agarose compound rest thickness is about 3~3.5 millimeters, Co 60 illumination-based disinfection standby With.
Electron microscopic observation is scanned to obtained κ types carragheen/agarose compound rest cross section, its cross-sectional structure As shown in Figure 1.
Embodiment 3
A kind of dressing for skin compound rest containing ι types carragheen/agarose, be by ι types carragheen and agarose according to 50:The compound support frame material that 50 mass ratio is constituted, stretch modulus 0.321MPa.
The preparation method of the above-mentioned dressing for skin compound rest containing ι types carragheen/agarose, comprises the following steps:
(1) it is 10% commerical grade ι-carrageenan solutions to prepare mass fraction, is placed in 90 DEG C of water-baths and is heated to being completely dissolved, Filter while hot.Add same volume 0.8mol/L KCl solution.50mL centrifuge tubes high speed centrifugation (8000rpm, 20min) is inserted, Abandoning supernatant.Taking precipitate is dialysed three days in molecular cut off is 3000 bag filter, concentrated by rotary evaporation.Insert -20 DEG C of ice Deep colling is stayed overnight in case, freeze-drying.
(2) agarose is dissolved with 90 DEG C of pure water, obtains the agarose solution that mass fraction is 1%.
(3) the ι type carragheens purified are added in above-mentioned agarose solution, and under 90 DEG C, 600r/min constantly Stirring is well mixed it, and solution bubble-free obtains carragheen/agarose blend solution.The wherein matter of carragheen and agarose Amount is than being 50:50.
(4) blend solution obtained by step (3) is poured into mould and cooled down, the height of blend solution in a mold is about 4 millis Rice, is then placed in 4~5h of freezing at -20 DEG C by mould.The mould of deep colling is put into freeze drier, condenser temperature for- 30~-60 DEG C, pumping freeze-drying 36h under conditions of vacuum, are made ι types carragheen/agarose compound rest.
Obtained ι types carragheen/agarose compound rest thickness is about 3~3.5 millimeters, Co 60 illumination-based disinfection standby With.
Electron microscopic observation is scanned to obtained ι types carragheen/agarose compound rest cross section, its cross-sectional structure As shown in Figure 2.
ι types carragheen/effect of the agarose compound rest in 3T3 cytotoxicity experiments:In 37 DEG C, 5%CO2Condition Under ι types carragheen/agarose compound rest 24h leaching liquors are prepared with 0.1g/mL concentration, gained leaching liquor is added to and carried The good 3T3 cell densities of preceding kind are 1*10572h is cultivated in 24 orifice plates in individual/hole.Measured after 72h experimental group cell survivaling number with it is right It is experimental group 98.7% according to a group no significant difference, it was demonstrated that gained ι types carragheen/agarose compound rest safety, acellular poison Property.
Above-described embodiment is preferably embodiment, but embodiments of the present invention are not by above-described embodiment of the invention Limitation, other any Spirit Essences without departing from the present invention and the change made under principle, modification, replacement, combine, simplification, Equivalent substitute mode is should be, is included within protection scope of the present invention.

Claims (10)

1. a kind of dressing for skin containing carragheen/agarose, it is characterised in that described dressing for skin is by carragheen and fine jade Lipolysaccharide is with (10:90)~(50:50) after mass ratio blending, be cooled into gel has three-dimensional by what freeze-drying was obtained again The laminated film that convection drying is obtained after the compound support frame material of porous laminated structure, or blending;Described carragheen is business Carragheen of the grade carragheen after purification processes.
2. a kind of dressing for skin containing carragheen/agarose according to claim 1, it is characterised in that the purification Process step is:Preparation mass fraction is 10% commerical grade carrageenan solutions, is placed in 90 DEG C of water-baths and dissolves by heating, while hot mistake Filter;Add same volume 0.8mol/L KCl solution;Stand or centrifuge at room temperature, take precipitation to be placed in bag filter and dialyse three My god, concentrated by rotary evaporation;Stay overnight, be freeze-dried in -20 DEG C of deep colling.
3. a kind of dressing for skin containing carragheen/agarose according to claim 1, it is characterised in that the OK a karaoke club Glue includes one kind in κ types carragheen, ι types carragheen or λ type carragheens.
4. a kind of dressing for skin containing carragheen/agarose according to claim 1, it is characterised in that described tool The compound support frame material thickness for having three-dimensional porous layer structure is 3~3.5 millimeters.
5. a kind of dressing for skin containing carragheen/agarose according to claim 1, it is characterised in that described answers It is 2~2.5 millimeters to close film thickness.
6. a kind of dressing for skin containing carragheen/agarose, it is characterised in that comprise the following steps:
(1) it is 10% commerical grade carrageenan solutions to prepare mass fraction, is placed in 90 DEG C of water-baths and dissolves by heating, filters while hot;Plus Enter same volume 0.8mol/L KCl solution;Stand or centrifuge at room temperature, take precipitation to be placed in bag filter and dialyse three days, rotation Inspissation contracts;Stay overnight, be freeze-dried in -20 DEG C of deep colling, it is standby;
(2) with the pure water dissolving agarose for being heated to 75~90 DEG C, stirring obtains the agarose that mass concentration is 1~2% molten Liquid;
(3) carragheen for purifying step (1) is added in step (2) in the agarose solution of gained, and temperature is maintained at 75~ 90 DEG C, stir and evenly mix, obtain carragheen/agarose blend solution, the wherein mass ratio of carragheen and agarose is (10:90)~ (50:50);
(4) blend solution obtained by step (3) is poured into convection drying in mould, obtains laminated film;Or blend solution is fallen Enter in mould, be placed under -20 DEG C of environment and freeze freeze-drying after 4~5h, obtain the composite support with three-dimensional porous layer structure Frame material.
7. a kind of dressing for skin containing carragheen/agarose according to claim 6, it is characterised in that step (1) institute State carragheen and preferably include one kind among κ types carragheen, ι types carragheen or λ type carragheens;
The bag filter molecular cut off used in being dialysed described in step (1) is 3000.
8. a kind of dressing for skin containing carragheen/agarose according to claim 6, it is characterised in that step (2), (3) mixing speed described in is 600r/min.
9. a kind of dressing for skin containing carragheen/agarose according to claim 6, it is characterised in that, step (4) Described in convection drying be by mould be placed at 20~35 DEG C dry 48~72h, skin of the gained containing carragheen/agarose Dressing is laminated film;
Freeze-drying described in step (4) be at -20~-30 DEG C freeze 4~5h after, in freeze drier cold-trap be -30 ~-60 DEG C, be evacuated in the state of vacuum and dry 36~48h, the dressing for skin containing carragheen/agarose of gained is with three Tie up the compound support frame material of porous laminated structure.
10. the dressing for skin containing carragheen/agarose described in any one of claim 1 to 5 is in dressing for skin and tissue work Application in engineering support Material Field.
CN201710169113.8A 2017-03-21 2017-03-21 A kind of preparation method and application of the dressing for skin containing carragheen/agarose Pending CN107096062A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710169113.8A CN107096062A (en) 2017-03-21 2017-03-21 A kind of preparation method and application of the dressing for skin containing carragheen/agarose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710169113.8A CN107096062A (en) 2017-03-21 2017-03-21 A kind of preparation method and application of the dressing for skin containing carragheen/agarose

Publications (1)

Publication Number Publication Date
CN107096062A true CN107096062A (en) 2017-08-29

Family

ID=59674719

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710169113.8A Pending CN107096062A (en) 2017-03-21 2017-03-21 A kind of preparation method and application of the dressing for skin containing carragheen/agarose

Country Status (1)

Country Link
CN (1) CN107096062A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108578761A (en) * 2018-04-12 2018-09-28 西南大学 Load the preparation method and applications of silk gum/Ago-Gel of lysozyme
CN113425644A (en) * 2021-07-16 2021-09-24 山东大学 Rose mask and preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0840882A (en) * 1994-07-29 1996-02-13 Ichimaru Pharcos Co Ltd Sheet for plastering skin
CN103386145A (en) * 2013-07-31 2013-11-13 暨南大学 Wound healing dressing containing carrageenan, and preparation method and application of wound healing dressing
CN103520767A (en) * 2013-10-28 2014-01-22 山东赛克赛斯药业科技有限公司 Anti-microbial healing-promoting hydrogel dressing and preparation method therefor
CN103948957A (en) * 2014-05-14 2014-07-30 广州创尔生物技术股份有限公司 Hydrophilic and hydrophobic agarose collagen dressing as well as preparation method and application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0840882A (en) * 1994-07-29 1996-02-13 Ichimaru Pharcos Co Ltd Sheet for plastering skin
CN103386145A (en) * 2013-07-31 2013-11-13 暨南大学 Wound healing dressing containing carrageenan, and preparation method and application of wound healing dressing
CN103520767A (en) * 2013-10-28 2014-01-22 山东赛克赛斯药业科技有限公司 Anti-microbial healing-promoting hydrogel dressing and preparation method therefor
CN103948957A (en) * 2014-05-14 2014-07-30 广州创尔生物技术股份有限公司 Hydrophilic and hydrophobic agarose collagen dressing as well as preparation method and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
张建新: "琼脂糖和卡拉胶在凝胶中的相互作用", 《华东化工学院学报》 *
易静楠: "含硫酸酯海藻多糖/Ⅰ型胶原复合支架的制备及用于皮肤再生修复的研究", 《暨南大学硕士学位论文》 *
梁婉爱: "卡拉胶硫酸酯衍生物抗凝血及其细胞毒性构效关系研究", 《暨南大学硕士学位论文》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108578761A (en) * 2018-04-12 2018-09-28 西南大学 Load the preparation method and applications of silk gum/Ago-Gel of lysozyme
CN113425644A (en) * 2021-07-16 2021-09-24 山东大学 Rose mask and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN106902381B (en) Recombinant human collagen stock solution, dressing and preparation method thereof
CN103083713B (en) A kind of aseptic polymerization wound-surface cover dressing
CN109045349A (en) A kind of hydrogel skin wound dressing and preparation method thereof that antibacterial heal-promoting closes
US9827293B2 (en) Non-surgical, localized delivery of compositions for placental growth factors
US10517931B2 (en) Non-surgical, localized delivery of compositions for placental growth factors
CN107432951B (en) Sodium alginate-chitosan dressing loaded with tetrahydrocurcumin nanoparticles and preparation method thereof
CN106822988A (en) Alginate fibre functional dressing and its application, alginate fibre functional dressing patch
CN104368031A (en) Medical antibacterial dressing and preparation method thereof
KR100324164B1 (en) Layered air-gap sheet of chitosan and process therefor
CN112089883B (en) Medical cold compress dressing and preparation method thereof
EP1404281B1 (en) Pharmaceutical compositions of topic use, applied in treatment of skin and/or mucous injuries; use of compositions in treatment of skin and/or mucous injuries and use of compounds in treatment of skin and/or mucous injuries
CN107096062A (en) A kind of preparation method and application of the dressing for skin containing carragheen/agarose
CN113663137A (en) Composite biological patch and preparation method and application thereof
CN112587719A (en) Antibacterial hemostatic membrane and preparation method and application thereof
CN105687036B (en) Bletilla skin-protection product and preparation method thereof
CN109700998B (en) Compound skin injury regeneration repairing agent and preparation method thereof
CN103386145B (en) Wound healing dressing containing carrageenan, and preparation method and application of wound healing dressing
CN114668883B (en) Preparation method of curcumin-loaded sodium alginate/polyvinyl alcohol/silk fibroin composite scaffold
CN108452370A (en) A kind of compound supramolecular hydrogel and preparation method thereof
CN104910404B (en) A kind of chitosan-glycerine-nano silver sponge and its preparation method and application
CN116869950B (en) Blood pressure-reducing biodegradable subcutaneous implantation rod and preparation method thereof
CN112206307B (en) Injectable temperature-sensitive hydrogel and preparation method and application thereof
CN108210983A (en) A kind of nasal cavity is grafted hyaluronic acid sponge and preparation method thereof with agarose
CN108404193B (en) Bletilla striata hemostatic bandage product and preparation method thereof
CN115414517A (en) Composite alginate medical dressing containing fucose oligosaccharide and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170829

RJ01 Rejection of invention patent application after publication